| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 10/03/2006 | CA2225741C Ionophore antibiotic formulations |
| 10/03/2006 | CA2218370C Chewable tablet with effervescent action |
| 10/03/2006 | CA2213842C Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence |
| 10/03/2006 | CA2213188C Treatment of vascular thrombosis and restenosis with inhaled nitric oxide |
| 10/03/2006 | CA2189094C Sugarless coating produced by hard coating, process |
| 10/03/2006 | CA2099493C Water-soluble delivery systems for hydrophobic liquids |
| 10/03/2006 | CA2082495C A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols |
| 09/30/2006 | CA2503087A1 Intravenous formulations of pyridoxal 5'-phosphate and method of preparation |
| 09/29/2006 | CA2554633A1 Galenic formulations of organic compounds |
| 09/28/2006 | WO2006102412A2 Method and system for providing integrated medication infusion and analyte monitoring system |
| 09/28/2006 | WO2006102395A2 Delivery systems and methods for diagnosing and treating cardiovascular diseases |
| 09/28/2006 | WO2006102377A2 Functionalized magnetic nanoparticles and methods of use thereof |
| 09/28/2006 | WO2006102345A2 Methods and systems for operating an aerosol generator |
| 09/28/2006 | WO2006102267A2 New neuronal pain pathway |
| 09/28/2006 | WO2006102179A2 Confection for teeth whitening and oral hygiene |
| 09/28/2006 | WO2006102163A2 Transfection reagents for non-adherent suspension cells |
| 09/28/2006 | WO2006102157A1 Crystallization inhibitor and its use in gelatin capsules |
| 09/28/2006 | WO2006102117A1 Nanoparticulate biphosphonate compositions |
| 09/28/2006 | WO2006102080A1 Polymer adhesive splicing of water-soluble, orally-ingestible thin film webs |
| 09/28/2006 | WO2006102070A2 Sclerostin and the inhibition of wnt signaling and bone formation |
| 09/28/2006 | WO2006101945A2 Agglomerated starch compositions |
| 09/28/2006 | WO2006101864A1 Antibacterial 5',5-disubstituted 3,3'-dialkoxy-2,2'-dihydroxy- 1,1'-biphenyl compounds and related methods |
| 09/28/2006 | WO2006101846A1 Dosing regimen of flavopiridol for treating cancer in particular cll |
| 09/28/2006 | WO2006101839A2 Enhanced bimatoprost ophthalmic solution |
| 09/28/2006 | WO2006101815A2 Pharmaceutical compositions comprising polyoxaester and active agents for use with osmotic delivery systems |
| 09/28/2006 | WO2006101794A2 Stable tablet dosage forms of proton pump inhibitors |
| 09/28/2006 | WO2006101782A2 A cysteine-containing peptide tag for site-specific conjugation of proteins |
| 09/28/2006 | WO2006101536A1 Fast-melting tablets having taste-masking and sustained release properties |
| 09/28/2006 | WO2006101173A1 Preparation comprising microparticles of complex composed of nucleic acid molecule and collagen |
| 09/28/2006 | WO2006100875A1 Pharmaceutical composition |
| 09/28/2006 | WO2006100687A1 Disodium pamidronate aqueous formulation |
| 09/28/2006 | WO2006100602A2 Immediate release stable solid oral dosage forms op fosinopril |
| 09/28/2006 | WO2006100574A1 Amorphous cefditoren pivoxil granules and processes for the preparation thereof |
| 09/28/2006 | WO2006100567A1 Charged lipoprotein complexes and their uses |
| 09/28/2006 | WO2006100561A1 Multi-ply technical composite which is breathable and moisturising, releases active constituents and promotes their absorption, and can be used as a medical aid or to make clothing or structures that come into direct contact with healthy or diseased skin |
| 09/28/2006 | WO2006100527A1 Effervescent tablet containing sodium alendronate and related use and process |
| 09/28/2006 | WO2006100489A2 A transdermal topical composition and its uses |
| 09/28/2006 | WO2006100485A1 A topical composition and its uses |
| 09/28/2006 | WO2006100308A2 Compositions comprising microcapsules consisting of autolysed microbial cells and encapsulated material |
| 09/28/2006 | WO2006100305A2 Metal chelates of polyaminocarboxylic macrocyclic derivatives and use thereof in diagnostic imaging |
| 09/28/2006 | WO2006100251A1 Transdermal patch |
| 09/28/2006 | WO2006100060A2 Colloidal nanocomposites comprising lbl-particles, lipids and biological components and method for the production thereof |
| 09/28/2006 | WO2006099946A1 Transdermal therapeutic system |
| 09/28/2006 | WO2006099877A1 Rectal and vaginal suppositories containing bioadhesive bromocriptine and poloxamer |
| 09/28/2006 | WO2006099865A2 Tablet-type controlled-release preparation containing cinnarizine and dimenhydrinate for combating vertigo |
| 09/28/2006 | WO2006099864A2 Pellet-type controlled-release preparation containing cinnarizine and dimenhydrinate for combating vertigo |
| 09/28/2006 | WO2006099818A1 Light curable monomer compostion and use thereof |
| 09/28/2006 | WO2006099804A1 Herbal compositions useful in cancer treatment |
| 09/28/2006 | WO2006099779A1 A rgd-containing cyclic peptid and the active-targeting liposome thereof |
| 09/28/2006 | WO2006099687A1 Sunscreen aerosol spray |
| 09/28/2006 | WO2006099651A1 Liquid aqueous dosage forms for sub-lingual or nasal applications of active agents with amino groups |
| 09/28/2006 | WO2006087358A3 Composition for adjusting water quality for administration of water sanitizer sensitive medicaments or vaccines |
| 09/28/2006 | WO2006085217A3 Solid adsorbates of hydrophobic drugs |
| 09/28/2006 | WO2006084161A3 Anti-microbial granules |
| 09/28/2006 | WO2006083761A3 Solvent/polymer solutions as suspension vehicles |
| 09/28/2006 | WO2006083388A8 Coated/treated metal silicate absorbent particles |
| 09/28/2006 | WO2006082523A3 Pharmaceutical sustained release composition of metformin |
| 09/28/2006 | WO2006082328A3 Compositions comprising dehydrated micro-organisms, method for preparing same, and uses thereof |
| 09/28/2006 | WO2006079922A3 Fast-disintegrating microporous binder and process for making it |
| 09/28/2006 | WO2006072067A3 Antimicrobial biomaterial for blood bags |
| 09/28/2006 | WO2006067867A8 Cell adhesion factor expression inhibitor |
| 09/28/2006 | WO2006058236A3 Composition comprising an nmda receptor antagonist and levodopa and use thereof for treating neurological disease |
| 09/28/2006 | WO2006054175A3 Stable dosage forms of acid labile drug |
| 09/28/2006 | WO2006039460A3 Contact lens with biocidal activity, process of manufacture, use of the contact lens, and kit |
| 09/28/2006 | WO2006031787A3 Low-obscuration image transmitting particulate ocular therapeutic formulations |
| 09/28/2006 | WO2006023654A3 Awat-related methods and articles |
| 09/28/2006 | WO2006015861A3 Drop preparations comprising dimetindene |
| 09/28/2006 | WO2005118052A3 Infusion apparatus |
| 09/28/2006 | WO2005107714A3 Method of forming microparticles that include a bisphosphonate and a polymer |
| 09/28/2006 | WO2005070393A3 Directly compressible pharmaceutical composition of the rapamycin ester cci-779 |
| 09/28/2006 | WO2005065654A3 Rosiglitazone formulations |
| 09/28/2006 | US20060217798 Stent having active release reservoirs |
| 09/28/2006 | US20060217444 Tramadol for the treatment of functional gastrointestinal disorders |
| 09/28/2006 | US20060217397 Sustained release ranolazine formulations |
| 09/28/2006 | US20060217321 Compositions to improve tic disorders |
| 09/28/2006 | US20060217320 Soft gel formulations for saquinavir |
| 09/28/2006 | US20060217313 5-CNAC as oral delivery agent for parathyroid hormone fragments |
| 09/28/2006 | US20060217309 Novel cyclosporine analog formulations |
| 09/28/2006 | US20060216799 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide |
| 09/28/2006 | US20060216355 Encapsulated pharmaceuticals in a medium having non-encapsulated flavoring agents |
| 09/28/2006 | US20060216354 Vector for oral administration |
| 09/28/2006 | US20060216353 Nanoparticulate corticosteroid and antihistamine formulations |
| 09/28/2006 | US20060216352 Rapid-acting pharmaceutical composition |
| 09/28/2006 | US20060216351 Pharmaceutical Compositions of Dispersions of Drugs and Neutral Polymers |
| 09/28/2006 | US20060216350 Ganglionic blocking agents for the treatment of epithelial diseases |
| 09/28/2006 | US20060216349 Ibuprofen composition |
| 09/28/2006 | US20060216348 Agglomerated starch compositions |
| 09/28/2006 | US20060216347 Tablet punches and methods for tableting |
| 09/28/2006 | US20060216346 Dosage form containing (s)-pantoprazole as active ingredient |
| 09/28/2006 | US20060216345 Oral pharmaceutical composition including paroxetine |
| 09/28/2006 | US20060216344 Pharmaceutical compositions and dosage forms of thalidomide |
| 09/28/2006 | US20060216343 Pharmaceutical compositions comprising an oligonucleotide as an active agent |
| 09/28/2006 | US20060216342 Micelle delivery system loaded with a pharmaceutical agent |
| 09/28/2006 | US20060216341 Compositions for treating drug resistance |
| 09/28/2006 | US20060216340 drug delivery at least two-day additional dosing interval; allows for reduced plasma concentrations over a prolonged time period while still providing effective pain management; transdermal delivery system maximizes the dosage interval |
| 09/28/2006 | US20060216339 Neuronal pain pathway |
| 09/28/2006 | US20060216338 Composition and method of treatment for heel pain |
| 09/28/2006 | US20060216337 Needeleless medication delivery system |
| 09/28/2006 | US20060216335 Pressure-sensitive adhesive for percutaneous absorption, pressure-sensitive adhesive composition for percutaneous absorption and preparation for percutaneous absorption |
| 09/28/2006 | US20060216334 Methods of manufacturing a medicated tampon assembly |